FDA Endorses Johnson & Johnson Single-Dose COVID-19 Vaccine

The FDA says Johnson & Johnson's vaccine guards against COVID-19. 

The agency reports the single-dose shot is safe to use and about 66% effective at preventing moderate to severe cases of the disease. 

An independent review panel will weigh in on the vaccine this Friday. 

The FDA will then use that information to make a final decision in the coming days.

Trending stories at Newsy.com

• Florida System To Distribute Vaccines Found To Be Full Of Inequities
• Johnson & Johnson Begins Vaccine Distribution In The U.S.
• Teachers, Essential Workers Eligible For Vaccines In Los Angeles